Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 101

Sort by

Sort Order Select

Journal Articles

Minimal residual disease and stem cell transplantation outcomes

Jacqueline Cloos, Gert J. Ossenkoppele, Richard Dillon

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 617–625.

https://doi.org/10.1182/hematology.2019000006

Published: 2019

Journal Articles

Inflammatory bone marrow microenvironment

Nils B. Leimkühler, Rebekka K. Schneider

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 294–302.

https://doi.org/10.1182/hematology.2019000045

Published: 2019

Journal Articles

MRD evaluation of AML in clinical practice: are we there yet?

Sylvie D. Freeman, Christopher S. Hourigan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 557–569.

https://doi.org/10.1182/hematology.2019000060

Published: 2019

Journal Articles

Integrating patient-centered factors in the risk assessment of MDS

Rena J. Buckstein

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 373–380.

https://doi.org/10.1182/hematology.2019000041

Published: 2019

Journal Articles

Using genomics to define pediatric blood cancers and inform practice

Rachel E. Rau, Mignon L. Loh

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 286–300.

https://doi.org/10.1182/asheducation-2018.1.286

Published: 2018

Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.

https://doi.org/10.1182/asheducation-2018.1.264

Published: 2018

Journal Articles

On the architecture of translational research designed to control chronic lymphocytic leukemia

Michael Hallek

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 1–8.

https://doi.org/10.1182/asheducation-2018.1.1

Published: 2018

Journal Articles

Long-term complications in adolescent and young adult leukemia survivors

K. Scott Baker, Karen L. Syrjala

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 146–153.

https://doi.org/10.1182/asheducation-2018.1.146

Published: 2018

Journal Articles

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Monika Brüggemann, Michaela Kotrova

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 13–21.

https://doi.org/10.1182/asheducation-2017.1.13

Published: 2017

Journal Articles

Pediatric leukemia susceptibility disorders: manifestations and management

Lisa J. McReynolds, Sharon A. Savage

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 242–250.

https://doi.org/10.1182/asheducation-2017.1.242

Published: 2017

Journal Articles

Novel approaches to therapy in CML

Ravi Bhatia

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 115–120.

https://doi.org/10.1182/asheducation-2017.1.115

Published: 2017

Journal Articles

The role of targeted therapy in the management of patients with AML

Alexander E. Perl

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 54–65.

https://doi.org/10.1182/asheducation-2017.1.54

Published: 2017

Journal Articles

Chronic neutropenia in LGL leukemia and rheumatoid arthritis

Tal Gazitt, Thomas P. Loughran, Jr.

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 181–186.

https://doi.org/10.1182/asheducation-2017.1.181

Published: 2017

Journal Articles

Acquired ribosomopathies in leukemia and solid tumors

Adrianna Vlachos

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 716–719.

https://doi.org/10.1182/asheducation-2017.1.716

Published: 2017

Journal Articles

Can we make a better match or mismatch with KIR genotyping?

Rohtesh S. Mehta, Katayoun Rezvani

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 106–118.

https://doi.org/10.1182/asheducation-2016.1.106

Published: 2016

Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.

https://doi.org/10.1182/asheducation-2016.1.323

Published: 2016

Journal Articles

Germ line mutations associated with leukemias

Christopher C. Porter

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 302–308.

https://doi.org/10.1182/asheducation-2016.1.302

Published: 2016

Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.

https://doi.org/10.1182/asheducation-2016.1.356

Published: 2016

Journal Articles

Discussing and managing hematologic germ line variants

Wendy Kohlmann, Joshua D. Schiffman

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 309–315.

https://doi.org/10.1182/asheducation-2016.1.309

Published: 2016

Journal Articles

What's different about atypical CML and chronic neutrophilic leukemia?

Kim-Hien T. Dao, Jeffrey W. Tyner

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 264–271.

https://doi.org/10.1182/asheducation-2015.1.264

Published: 2015

NARROW

Minimal residual disease and stem cell transplantation outcomes

Inflammatory bone marrow microenvironment

MRD evaluation of AML in clinical practice: are we there yet?

Integrating patient-centered factors in the risk assessment of MDS

Using genomics to define pediatric blood cancers and inform practice

Clinical consequences of clonal hematopoiesis of indeterminate potential

On the architecture of translational research designed to control chronic lymphocytic leukemia

Long-term complications in adolescent and young adult leukemia survivors

Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation

Pediatric leukemia susceptibility disorders: manifestations and management

Novel approaches to therapy in CML

The role of targeted therapy in the management of patients with AML

Chronic neutropenia in LGL leukemia and rheumatoid arthritis

Acquired ribosomopathies in leukemia and solid tumors

Can we make a better match or mismatch with KIR genotyping?

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Germ line mutations associated with leukemias

MRD in AML: does it already guide therapy decision-making?

Discussing and managing hematologic germ line variants

What's different about atypical CML and chronic neutrophilic leukemia?

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only